Sort
130,381 grants matching “hiv”
Bone Marrow Transplantation in Human Disease
$1,853,411Richard J Jones · Johns Hopkins University · P01 · FY2016 · CA
Bone Marrow Transplantation in Human Disease
$1,853,411Richard J Jones · Johns Hopkins University · P01 · FY2015 · CA
Multilevel Influences on HIV and Substance use in a YMSM Cohort
$1,853,076Brian Mustanski · Northwestern University At Chicago · U01 · FY2018 · DA
Induction of neutralizing antibodies targeting CD4 binding region of HIV-1 Env
$1,852,576Shan Lu · Univ Of Massachusetts Med Sch Worcester · P01 · FY2010 · AI
HIV PREVENTION AND CARE SERVICES FOR YOUNG PEOPLE IN KENYA
$1,851,609Kawango Agot · Impact Research And Development Org · U62 · FY2008 · PS
Baylor-UT Houston Center for AIDS Research
$1,851,127Janet S Butel · Baylor College Of Medicine · P30 · FY2011 · AI
Intravaginal Ring Delivery of Safe & Effective Microbicides to Prevent HIV & HSV
$1,850,988Betsy C. Herold · Albert Einstein College Of Medicine · U19 · FY2011 · AI
THE NIH NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - NEW CLINICAL SITE
$1,850,908Beau M Ances · Washington University · N01 · FY2024 · DA
Investigating Transcriptional Responses to the Environment
$1,850,755Karen L Adelman · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
SUPPORTING THE IMPLEMENTATION AND EXPANSION OF HIGH QUALITY HIV
$1,850,467Craig R Cohen · University Of California, San Francisco · U2G · FY2012 · PS
Immunologic &Virologic Features of Early HIV Infection
$1,850,423University Of California San Francisco · U01 · FY2003 · AI
PLANNING, IMPLEMENTATON, EVALUATION OF COMPREHENSIVE HIV PREVENTION (PEPFAR)
$1,850,000Harry Peter Hausler · Tb Hiv Care · U2G · FY2013 · GH
PROVISION OF FULL ACCESS HOME BASED CONFIDENTIAL HIV COUNSELING AND TESTING
$1,850,000Elly Muganzi · Integrated Community Based Initiatives · U2G · FY2008 · PS
Complementing broadly neutralizing antibodies and autologous responses to restrict virus escape and durably suppress HIV-1
$1,849,302Katharine June Bar · University Of Pennsylvania · U01 · FY2025 · AI
Combination immunotherapy with gene modified CD4 and CD8 T cells and stem cells
$1,848,744Carl H. June · University Of Pennsylvania · U19 · FY2010 · AI
Integrase Defective Lentiviral Vector (IDLV)-ENV Immunogen Strategy for an HIV Vaccine
$1,848,708Mary E. Klotman · Duke University · P01 · FY2015 · AI
HIV/AIDS Vaccine Development
$1,848,705John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Non Human Primate Models of SIV and HIV Immune Protection
$1,848,705John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Global Cancer Health
$1,848,679Philip Castle · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA
DESIGN OF NOVEL IMMUNOGENS AND ADJUVANTS FOR HIV VACCINE
$1,848,562Duke University · P01 · FY2001 · AI
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana
$1,848,151Roger L Shapiro · Harvard School Of Public Health · U01 · FY2020 · AI
Functional Genomics and HCV-Associated Liver Disease
$1,848,035Michael G Katze · University Of Washington · P30 · FY2010 · DA
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU
$1,847,715Myron E Essex · Harvard School Of Public Health · U01 · FY2011 · AI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins
$1,847,653Paolo Lusso · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Discovery of an Orexin-1 receptor antagonist for treatment of cocaine addiction and dependence
$1,847,427Fiona Marshall · Heptares Therapeutics, Ltd · R01 · FY2015 · DA